Inventor · disambiguated record
Christophe Peixoto
Also filed as: PEIXOTO CHRISTOPHE
19 granted patents·4 pending applications·54 citations·filing 2009–2022
92Inventor score
Files withGALAPAGOS NV19AKASHI THERAPEUTICS INC1BUSH ERNEST D1DART THERAPEUTICS LLC1ONCO3R THERAPEUTICS BV1
Top patents by PatentIndex Score
23 records- 0192US9670204B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Jun 6, 2017·10 cites·20 claims
- 0290US9926281B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2015·Granted Mar 27, 2018·6 cites·18 claims
- 0390US9249141B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Feb 2, 2016·9 cites·12 claims
- 0489US11072611B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2019·Granted Jul 27, 2021·2 cites·15 claims
- 0589US10125132B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2017·Granted Nov 13, 2018·6 cites·20 claims
- 0688US10526329B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2018·Granted Jan 7, 2020·4 cites·3 claims
- 0788US10487060B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2018·Granted Nov 26, 2019·4 cites·28 claims
- 0888US8993590B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Mar 31, 2015·8 cites·17 claims
- 0980US11339166B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2018·Granted May 24, 2022·2 cites·20 claims
- 1077US2023022534A1Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2021·Application pending·0 cites
- 1173US7968581B2Imidazolidine compounds as androgen receptor modulatorsGALAPAGOS NV·Filed 2009·Granted Jun 28, 2011·2 cites·57 claims
- 1270US9796719B2Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Oct 24, 2017·1 cites·15 claims
- 1369US11718588B25-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2021·Granted Aug 8, 2023·0 cites·16 claims
- 1468US10941117B25-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritisGALAPAGOS NV·Filed 2019·Granted Mar 9, 2021·0 cites·4 claims
- 1566US12065443B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2022·Granted Aug 20, 2024·0 cites·29 claims
- 1648US2016250188A1Methods for treatment of muscular dystrophiesBUSH ERNEST D·Filed 2014·Application pending·0 cites
- 1748US2018127425A1Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2017·Application pending·0 cites
- 1846US2019167640A1Methods for treatment of muscular dystrophiesAKASHI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1942US12264156B2Compounds and pharmaceutical compositions thereof for the treatment of diseasesGALAPAGOS NV·Filed 2019·Granted Apr 1, 2025·0 cites·20 claims
- 2041US12391679B2Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseasesONCO3R THERAPEUTICS BV·Filed 2020·Granted Aug 19, 2025·0 cites·15 claims
- 2138US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 2237US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
- 2337US8383608B2Imidazolidine compounds as androgen receptor modulatorsDART THERAPEUTICS LLC·Filed 2011·Granted Feb 26, 2013·0 cites·56 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →